Free Trial

Synopsys (SNPS) Expected to Announce Quarterly Earnings on Tuesday

Synopsys logo with Computer and Technology background

Key Points

  • Synopsys is set to announce its Q3 2025 earnings on September 9th, with analysts predicting earnings of $3.84 per share and revenue of $1.7662 billion.
  • Recent analyst upgrades include price targets raised by Morgan Stanley to $715 and Rosenblatt Securities to $650, reflecting a consensus rating of "Moderate Buy" for the stock.
  • Insider trading has been notable, with CFO Shelagh Glaser reducing her holdings by over 32% and CRO Richard S. Mahoney selling nearly 86% of his shares.
  • MarketBeat previews top five stocks to own in October.

Synopsys (NASDAQ:SNPS - Get Free Report) is expected to be announcing its Q3 2025 results after the market closes on Tuesday, September 9th. Analysts expect Synopsys to post earnings of $3.84 per share and revenue of $1.7662 billion for the quarter. Individuals are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Tuesday, September 9, 2025 at 5:00 PM ET.

Synopsys Trading Down 1.4%

Shares of SNPS opened at $603.52 on Tuesday. Synopsys has a 12-month low of $365.74 and a 12-month high of $651.73. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01. The firm has a market capitalization of $93.64 billion, a price-to-earnings ratio of 43.58, a P/E/G ratio of 3.97 and a beta of 1.14. The stock's 50-day moving average price is $585.72 and its 200 day moving average price is $503.81.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Morgan Stanley restated an "overweight" rating and set a $715.00 price target (up from $540.00) on shares of Synopsys in a research note on Monday, August 11th. Rosenblatt Securities upped their price objective on Synopsys from $625.00 to $650.00 and gave the company a "buy" rating in a research note on Friday, July 25th. Bank of America upped their price objective on Synopsys from $575.00 to $625.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. Needham & Company LLC reiterated a "buy" rating and issued a $660.00 price objective (up from $650.00) on shares of Synopsys in a research note on Tuesday, July 15th. Finally, KeyCorp upped their price objective on Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a research note on Thursday, July 10th. Twelve research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $634.64.

Get Our Latest Report on SNPS

Insider Activity at Synopsys

In other news, CFO Shelagh Glaser sold 7,310 shares of the business's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $485.72, for a total value of $3,550,613.20. Following the transaction, the chief financial officer directly owned 15,291 shares of the company's stock, valued at $7,427,144.52. The trade was a 32.34% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CRO Richard S. Mahoney sold 9,010 shares of the company's stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total value of $4,245,602.10. Following the transaction, the executive directly owned 1,485 shares in the company, valued at approximately $699,746.85. This represents a 85.85% decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.

Institutional Trading of Synopsys

Institutional investors and hedge funds have recently made changes to their positions in the business. Resources Management Corp CT ADV raised its stake in shares of Synopsys by 1.2% during the 2nd quarter. Resources Management Corp CT ADV now owns 2,639 shares of the semiconductor company's stock worth $1,353,000 after buying an additional 31 shares in the last quarter. Brighton Jones LLC raised its stake in shares of Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock worth $447,000 after buying an additional 50 shares in the last quarter. WINTON GROUP Ltd raised its stake in shares of Synopsys by 9.2% during the 2nd quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company's stock worth $389,000 after buying an additional 64 shares in the last quarter. Integrated Wealth Concepts LLC raised its stake in shares of Synopsys by 11.6% during the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company's stock worth $326,000 after buying an additional 79 shares in the last quarter. Finally, EP Wealth Advisors LLC raised its stake in shares of Synopsys by 2.8% during the 2nd quarter. EP Wealth Advisors LLC now owns 2,992 shares of the semiconductor company's stock worth $1,534,000 after buying an additional 81 shares in the last quarter. Institutional investors own 85.47% of the company's stock.

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More

Earnings History for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines